KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Co-Diagnostics (CODX) Revenue (2017 - 2025)

Historic Revenue for Co-Diagnostics (CODX) over the last 9 years, with Q3 2025 value amounting to $145380.0.

  • Co-Diagnostics' Revenue fell 7732.48% to $145380.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $507892.0, marking a year-over-year decrease of 9306.25%. This contributed to the annual value of $3.9 million for FY2024, which is 4252.59% down from last year.
  • According to the latest figures from Q3 2025, Co-Diagnostics' Revenue is $145380.0, which was down 7732.48% from $162910.0 recorded in Q2 2025.
  • In the past 5 years, Co-Diagnostics' Revenue ranged from a high of $30.1 million in Q3 2021 and a low of $50277.0 during Q1 2025
  • In the last 5 years, Co-Diagnostics' Revenue had a median value of $2.5 million in 2023 and averaged $7.5 million.
  • Per our database at Business Quant, Co-Diagnostics' Revenue plummeted by 9734.81% in 2023 and then skyrocketed by 124315.44% in 2024.
  • Quarter analysis of 5 years shows Co-Diagnostics' Revenue stood at $20.4 million in 2021, then plummeted by 93.13% to $1.4 million in 2022, then surged by 153.67% to $3.6 million in 2023, then plummeted by 95.8% to $149325.0 in 2024, then fell by 2.64% to $145380.0 in 2025.
  • Its Revenue was $145380.0 in Q3 2025, compared to $162910.0 in Q2 2025 and $50277.0 in Q1 2025.